PRAF2: A Potential Drug Target and Biomarker (G11230)

Target Name: PRAF2

NCBI ID: G11230

PRAF2

PRAF2: A Potential Drug Target and Biomarker

PRAF2, or PPAR未2, is a gene that encodes a protein known as peroxisome proliferator-activated receptor delta (PPAR未) 2.PPAR未2 is a key transcription factor that regulates various cellular processes, including inflammation, cell growth, and metabolism. It is a highly conserved gene that is expressed in various tissues and organs, including adipose tissue, muscle, liver, and brain.

The PPAR未2 gene has been identified as a potential drug target in the field of pharmacology due to its involvement in various diseases, including obesity, type 2 diabetes, and inflammation. It is known to regulate the expression of genes that are involved in the development and maintenance of these diseases, making it a promising target for therapeutic intervention.

PRAF2 has also been identified as a potential biomarker for several diseases, including obesity and type 2 diabetes. It has been shown to be positively correlated with body mass index (BMI) and with the levels of fasting plasma glucose (FPG) in individuals with type 2 diabetes. Additionally, it has been shown to be elevated in individuals with obesity, which may be a potential indicator of the disease.

The discovery and characterization of PRAF2 as a potential drug target and biomarker has important implications for the development of new therapeutic approaches for the treatment of these diseases. It may be possible to develop drugs that target PRAF2 to treat obesity and type 2 diabetes by inhibiting its activity or increasing its expression. This could be a valuable approach for the treatment of these diseases, as they are major contributors to the burden of morbidity and mortality in society.

In conclusion, PRAF2 is a promising drug target and biomarker that has the potential to be used to treat obesity and type 2 diabetes. Further research is needed to fully understand its role in these diseases and to develop effective therapies that target it.

Protein Name: PRA1 Domain Family Member 2

Functions: May be involved in ER/Golgi transport and vesicular traffic. Plays a proapoptotic role in cerulenin-induced neuroblastoma apoptosis

The "PRAF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRAF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets